Horizon Pharma Vimovo Suit Won’t Wait for Patent Board

A lawsuit over Horizon Pharma Inc.’s Vimovo will continue after a court declined to pause it while a patent review board decides whether the patents at issue in the case are valid.

The patent infringement suit in the U.S. District Court for the District of New Jersey shouldn’t be put on hold in favor of ongoing proceedings in the Patent Trial and Appeal Board because PTAB isn’t addressing all of the same issues and discovery has almost wrapped up in the court case, Judge Stanley Chesler ruled.

The decision means generic-drug makers will get a shot at knocking out ...